Barrett’s: Does radiofrequency ablation reduce the need for a follow-up?

CC BY-NC-ND 4.0 · Endosc Int Open 2019; 07(11): E1483-E1486
DOI: 10.1055/a-0996-8336

Editorial

Authors

Jan Martinek

¹Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

²Charles University, Institute of Physiology, First Faculty of Medicine, Prague, Czech Republic

³Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
Jana Krajciova

¹Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

²Charles University, Institute of Physiology, First Faculty of Medicine, Prague, Czech Republic

References
1 Weusten B, Bisschops R, Coron E. et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2017; 49: 191-198
2 Martinek J, Benes M, Brandtl P. et al. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrettʼs esophagus: a prospective cohort study. Endoscopy 2008; 40: 711-716
3 Shaheen NJ, Sharma P, Overholt BF. et al. Radiofrequency ablation in barrettʼs esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288
4 Orman ES, Nan LI, Shaheen NJ. Efficacy and durability of radiofrequency ablation for barrettʼs esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013; 11: 1245-1255
5 Krajciova J, Janicko M, Falt P. et al. Radiofrequency ablation in patients with Barrett’s esophagus-related neoplasia – long-term outcomes in the Czech National Database. J Gastrointest Liver Dis 2019; 28: 149-155
6 Shaheen NJ, Falk GW, Iyer PG. et al. ACG Clinical Guideline: Diagnosis and Management of Barrettʼs esophagus. Am J Gastroenterol 2016; 11: 30-50
7 Cotton CC, Haidry R, Thrift AP. et al. Development of evidence-based surveillance intervals after radiofrequency ablation of Barrett’s esophagus. Gastroenterology 2018; 155: 316-326.e6